Publicaciones en colaboración con investigadoras/es de Maastricht University (11)

2023

  1. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

    Psychiatry Research, Vol. 330

2017

  1. Superhydrophobic functionalization of cutinase activated poly(lactic acid) surfaces

    Green Chemistry, Vol. 19, Núm. 3, pp. 816-822

2016

  1. Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes

    Archives of Toxicology, Vol. 90, Núm. 5, pp. 1103-1115

2015

  1. Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro

    Toxicology in Vitro, Vol. 29, Núm. 3, pp. 489-501

2012

  1. 'Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans

    Toxicology and Applied Pharmacology, Vol. 259, Núm. 3, pp. 320-328

2011

  1. An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

    BMC Genomics, Vol. 12

  2. Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells

    BMC Systems Biology, Vol. 5

2010

  1. Neurocognition in bipolar disorders-A closer look at comorbidities and medications

    European Journal of Pharmacology, Vol. 626, Núm. 1, pp. 87-96

2007

  1. Functional impairment in patients with mania: Baseline results of the EMBLEM study

    Bipolar Disorders, Vol. 9, Núm. 1-2, pp. 45-52

2004

  1. The role of age in the development of Schneiderian symptoms in patients with a first psychotic episode

    Acta Psychiatrica Scandinavica, Vol. 109, Núm. 4, pp. 264-268

2003

  1. Age-dependence of Schneiderian psychotic symptoms in bipolar patients

    Schizophrenia Research, Vol. 61, Núm. 2-3, pp. 157-162